Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carla Neta"'
Autor:
Luís Pereira de Almeida, Amílcar Falcão, Ricardo Jorge dos Santos Lima, Carla Neta, Carlos Fontes-Ribeiro, Teresa G. Nunes, Susana Tavares, Patrício Soares-da-Silva, Tice Macedo
Publikováno v:
Drugs in R & D. 6:253-260
Purpose: To investigate the bioavailability and bioequivalence of three different formulations of eslicarbazepine acetate (BIA 2-093): 50 mg/mL oral suspension (test 1), 200mg tablets (test 2) and 800mg tablets (reference). Design, subjects and metho
Autor:
Carlos Fontes-Ribeiro, Ricardo Jorge dos Santos Lima, Carla Neta, Luís Pereira de Almeida, Amílcar Falcão, Rui Cerdeira, Tice Macedo, Teófilo Vasconcelos, José-Francisco Rocha, Patrício Soares-da-Silva, Teresa G. Nunes
Publikováno v:
Drugs in RD. 9(6)
Objective: To investigate the dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate (ESL) in healthy volunteers. Methods: This was a randomized, three-way crossover, single-centre study in 18 healthy v
Autor:
Carla Neta, Amílcar Falcão, C. Fontes-Ribeiro, Luís Pereira de Almeida, José-Francisco Rocha, Teresa G. Nunes, Patrício Soares-da-Silva, Tice Macedo, Manuel Vaz-da-Silva, Ana-Teresa Santos
Publikováno v:
European journal of clinical pharmacology. 64(10)
Nebicapone is a new catechol-O-methyltransferase inhibitor. In vitro, nebicapone has showed an inhibitory effect upon CYP2C9, which is responsible for the metabolism of S-warfarin. The objective of this study was to investigate the effect of nebicapo